RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Remiges Ventures
R

Remiges Ventures portfolio

Remiges Ventures has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $183M.
Latest deal: Glycomine · May 9, 2025.
About this page

Its most recent investment on record is Glycomine's $115M Series B+ round in May 2025, alongside Advent Life Sciences, RiverVest, Novo Holdings and 6 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with Sanofi Ventures, Abingworth and Novo Holdings, most often Sanofi Ventures (2 rounds).

What Remiges Ventures invests in

How Remiges Ventures invests

StageDealsCapital in rounds
Series B+ 2 100%$183M
YearDealsCapital in rounds
2021 1 50%$68M
2025 1 50%$115M

Remiges Ventures portfolio companies

CompanyRound with Remiges VenturesTotal raisedLatest raise
GGlycomine
Health and bio
Series B+ · $115M$195MMay 9, 2025
Series B+
CCyrano Therateutics
Health and bio
backerundisclosedMay 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Remiges Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Remiges Ventures, which is a subset of its real portfolio. API: /api/v1/investors/remiges-ventures (get a free API key). More: the most active VC firms and new venture capital funds.